Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In Follicular Lymphoma
Follicular Lymphoma for November/December 2017
Auto-HCT in People with FL, Early Therapy Failure, Biol Blood Marrow Transplant; ePub 2017 Dec 11; Casulo, et al
Follicular Lymphoma for September/October 2017
CAR-T Cell Therapy for Certain Lymphomas Approved, FDA news release; 2017 Oct 18
RIC in Patients with FL Receiving Allo-HCT, Biol Blood Marrow Transplant; ePub 2017 Oct 13; Epperla, et al
Accelerated Approval for New FL Treatment, FDA news release; 2017 Sep 14
Follicular Lymphoma for July/August 2017
Vitamin D Insufficiency and FL Outcomes, Blood Cancer J; ePub 2017 Aug 25; Tracy, et al
Grade 3 Follicular Lymphoma Outcomes Evaluated, Clin Lymphoma Myeloma Leuk; ePub 2017 Jul 13; Ali, et al
Follicular Lymphoma for May/June 2017
Risk of Second Primary Malignancies in Patients with FL, Clin Lymphoma Myeloma Leuk; ePub 2017 Jun 24; Giri, et al
New Treatment Approved for FL, DLBCL, and CLL, FDA news release; 2017 Jun 22
Rituximab + Chemo for Grade 3 Follicular Lymphoma, Clin Lymphoma Myeloma Leuk; ePub 2017 Jun 16; Yuan, et al
Why Certain Lymphomas May Respond to Targeted Treatment, Am J Hematol; ePub 2017 Jun 1; Binder, et al
Follicular Lymphoma for March/April 2017
Everolimus Evaluated for Indolent Non-Hodgkin Lymphomas, Am J Hematol; ePub 2017 Mar 10; Bennani, et al